Pharmagreen Biotech Files for Chapter 11 in Nevada Court

Aug. 12, 2020, 12:46 AM UTC

Pharmagreen Biotech has voluntarily filed for petitions for relief under chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Nevada.

  • “After taking much time to carefully analyze our strategic options, we have decided that a voluntary chapter 11 filing provides the best possible outcome for Pharmagreen,” said CEO Peter Wojcik. “We plan to engage all our lenders to settle debts in a way that is fair and beneficial for all parties going forward.”
  • The company plans to use the Chapter 11 process to build a comprehensive restructuring plan that will allow the company ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.